Yes, but you make it sound like such a big deal as if real investors are interested in a company with Mexedia's 2024 disaster of a balance sheet. If they were interested they would buy Mexedia's stock that is down 77% YOY, not this stinker. This stock is being used to raise capital for Mexedia, think real investors are interested in this end? Which is why the up-list narrative for this bloated pig at nearly 6.4 billion shares without a is also BS. The last time this Mexedia CFO boasted about a PCAOB Audit was in the February 6th press release that resulted in a 33% sell off on 512 million shares traded for the day. That was the headline right? "Raadr (Doing Business as Telvantis) Positions for National Exchange Uplisting With Strategic Engagement of PCAOB Audit Firm HTL International, LLC"
March 11 Is significant in that our CFO Daniel Gilcher will be discussing the much needed and awaited SEC approved PCAOB audit that is soon to be released.
Also the PCAOB audit’s significance with institutional investors
It sure looks to me from the price action since last Thursdays press release that most have seen it. 😆 Big announcement last Thursday about up-listing effort to the NYSE or NASDAQ certainly signals the reverse split and the stock sold off 33% on 512 million shares traded for the day. Then the Telvantis CEO follows that up with No, No, No,.. No reverse split, buy YES! we still will up-list to a national exchange. I'm not sure what country he is talking about but he isn't going to do in the U.S. He pretty much blew up the news of last Thursday. But they traded 228 million shares that day selling nearly all of it at 8. Now those people are down 25%.